Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

Cooper Companies (COO) stock in plain English

Free brief · no signupStart here
COOPublished Nov 13, 2026
Cooper Companies Inc
Healthcare · Medical Instruments & Supplies
Produces daily and monthly contact lenses for astigmatism, presbyopia, and pediatric myopia progression.
Assets:
CooperVision networkOperates manufacturing facilities in Costa Rica, Hungary, Puerto Rico, the UK, and the US.
CooperSurgical divisionSupplies fertility culture media, cryogenic storage, and IVF lab equipment across global reproductive clinics.
Paragard manufacturingProduces a long-acting hormone-free copper intrauterine device distributed directly to women's healthcare providers.
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

70
OPS ScoreOperating finances
Latest quote
-0.69%$60.33
$11.47B
20.6×
$4.23B

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 13, 2026Quotes updated Nov 20, 04:05 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was COO. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does Cooper Companies (COO) do?

Cooper Companies Inc (COO) is a U.S.-listed company in Healthcare (Medical Instruments & Supplies). What it does: Produces daily and monthly contact lenses for astigmatism, presbyopia, and pediatric myopia progression. Manufactures specialty toric, multifocal, and myopia contact lenses alongside clinical fertility and women's health. It is worth $11.47B on the market and sold $4.23B over the last year.

Market cap
$11.47B
P/E ratio
20.6×
Annual sales
$4.23B
Sector
Healthcare
Industry
Medical Instruments & Supplies
Brief updated
Nov 13, 2026

Brands and businesses behind COO

  • CooperVision: Produces and distributes contact lenses globally, earning revenue from wholesale shipments to optical distributors and eye doctors.
  • CooperSurgical: Supplies fertility technologies and gynecological devices, earning money through sales to reproductive laboratories and outpatient clinics.
  • Biofinity: Markets monthly replacement silicone hydrogel contact lenses for standard, toric, and multifocal prescriptions through eye care professionals.
  • Clariti: Sells daily disposable silicone hydrogel contact lenses through retail vision practices and optical chains worldwide.
  • MyDay: Produces premium daily disposable contact lenses made with breathable silicone materials sold via practitioner prescriptions.
  • MiSight: Generates sales from specialized daily contact lenses prescribed by doctors to slow nearsightedness progression in children.

COO’s flags, in plain English

Each flag is a number from Cooper Companies’ reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 13, 2026.

Wide Gross Margin

Gross margin of 61.4% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.

Low debt

Low debt, only 31% of shareholder equity. The company owes very little compared with what it earns, so a bad year is less likely to force its hand.

Fat Margins

Profit margin of 13.5%. The company keeps a healthy share of each sale as profit, which gives it room when costs jump.

Stock Piling Up

Law firms and investors are investigating channel inventory disclosures following sudden wholesale destocking in the United States. Unsold products are piling up faster than sales, which can lead to discounts and thinner profits.

2 more green flags open with the free trial. Try it free for 7 days.

Questions about COO

How big is Cooper Companies?

Cooper Companies’ market cap is $11.47B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $4.23B: what customers paid the company over the last year, before any costs.

What is COO’s P/E ratio?

COO’s P/E ratio is 20.6×. Investors pay about 20.6 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.

What could go wrong with COO?

The first risk note on the card is Stock Piling Up, explained above. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From Cooper Companies’ own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. COO’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card